Study: Moderna’s vaccine is 96% effective in teens

Moderna COVID-19 vaccinePhoto: AP Photo / Charlie Riedel / FILE
Advertisements

In a new study, Moderna’s coronavirus vaccine has been shown to be 96% effective against COVID-19 among people from 12 to 17 years old.

The results come from the company’s first clinical trials on people in this age group.

A total of 3,235 people participated in the study, which was conducted in the United States. Two out of three received the vaccine, while a third received an injection without a vaccine – as a control group.

The study also concluded that the participants tolerated the vaccines well. The side effects were mild or moderate and consisted of headache, fatigue, chills, and muscle pain – the same side effects that have been reported in adults.

Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews

Do you have a news tip for Norway Today? We want to hear it. Get in touch at info@norwaytoday.no

Advertisements

1 Comment on "Study: Moderna’s vaccine is 96% effective in teens"

  1. Mabinty Roy Bangura | 8. May 2021 at 12:20 | Reply

    That’s nice

Leave a comment

Your email address will not be published.


*